InsiderOther
Curet Myriam Insider Trading Activity
Every SEC Form 4 transaction reported by Curet Myriam, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Curet Myriam buying or selling?
Curet Myriam reported 0 open-market buys ($0) and 55 sells ($72.6M) across 55 Form 4 filings at 3 companies — a net selling position of $72.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 11, 2026)
Total Form 4 filings
55
SEC EDGAR
Companies
3
Buys (0)
$0
Sells (55)
$72.6M
Insider sentiment
Net sellingNet insider flow of $72.6M in net selling, filed between May 15, 2018 – Mar 11, 2026.
Companies Curet Myriam files for
Recent Curet Myriam transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 | ISRG | EVP & Chief Medical Officer | Sale | 105 | $51.9K |
| Mar 3, 2026 | ISRG | EVP & Chief Medical Officer | Sale | 4.9K | $2.4M |
| Mar 2, 2026 | ISRG | EVP & Chief Medical Officer | Sale | 2.3K | $1.2M |
| Feb 11, 2026 | ISRG | EVP & Chief Medical Officer | Sale | 526 | $260.3K |
| Jan 31, 2026 | ISRG | EVP & Chief Medical Officer | Sale | 126 | $65.5K |
| Jan 28, 2026 | ISRG | EVP & Chief Medical Officer | Sale | 230 | $122.5K |
| Dec 10, 2025 | ISRG | EVP & Chief Medical Officer | Sale | 104 | $58.2K |
| Dec 2, 2025 | ISRG | EVP & Chief Medical Officer | Sale | 125 | $71.1K |
| Nov 25, 2025 | INSP | Director | Sale | 1 | -$188.07 |
| Nov 12, 2025 | ISRG | EVP & Chief Medical Officer | Sale | 105 | $58.8K |
| Oct 29, 2025 | ISRG | EVP & Chief Medical Officer | Sale | 7.7K | $4.2M |
| Jul 25, 2025 | ISRG | EVP & Chief Medical Officer | Sale | 4.5K | $2.2M |
| Apr 28, 2025 | ISRG | EVP & Chief Medical Officer | Sale | 4.0K | $2.1M |
| Mar 4, 2025 | ISRG | EVP & Chief Medical Officer | Sale | 3.0K | $1.7M |
| Feb 27, 2025 | ISRG | EVP & Chief Medical Officer | Sale | 2.4K | $1.4M |
| Feb 11, 2025 | ISRG | EVP & Chief Medical Officer | Sale | 408 | $240.6K |
| Nov 13, 2024 | ISRG | EVP & Chief Medical Officer | Sale | 13.5K | $7.2M |
| Jul 24, 2024 | ISRG | EVP & Chief Medical Officer | Sale | 2.8K | $1.3M |
| Apr 24, 2024 | ISRG | EVP & Chief Medical Officer | Sale | 5.3K | $2.0M |
| Mar 1, 2024 | ISRG | EVP & Chief Medical Officer | Sale | 1.6K | $615.5K |
| Feb 27, 2024 | ISRG | EVP & Chief Medical Officer | Sale | 843 | $325.8K |
| Feb 13, 2024 | ISRG | EVP & Chief Medical Officer | Sale | 481 | $185.7K |
| Jan 29, 2024 | ISRG | EVP & Chief Medical Officer | Sale | 4.3K | $1.6M |
| Nov 17, 2023 | ISRG | EVP & Chief Medical Officer | Sale | 8.8K | $2.6M |
| Sep 21, 2023 | NKTR | Director | Sale | 4.4K | $3.0K |
Showing the 25 most recent filings of 55. Screen every filing.
Curet Myriam insider trading FAQ
Is Curet Myriam buying or selling?
Across 55 SEC Form 4 filings, Curet Myriam reported 0 open-market purchases totaling $0 and 55 sales totaling $72.6M — a net selling position of $72.6M.
Which companies does Curet Myriam file Form 4s for?
Curet Myriam has reported insider transactions at 3 companies, most often INTUITIVE SURGICAL INC (ISRG), NEKTAR THERAPEUTICS (NKTR), Inspire Medical Systems, Inc. (INSP).
How far back does Curet Myriam's filing history go?
Trabud holds Curet Myriam's SEC Form 4 filings from May 15, 2018 – Mar 11, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Curet Myriam's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Curet Myriam and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener